Access the world's leading financial data and tools

Subscribe for $2
Overview
Profile

KP Tissue stock

KPT.TO
CA48265Y1043
A1KAN1

Price

8.35
Today +/-
+0.02
Today %
+0.36 %

KP Tissue stock price

%
Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the KP Tissue stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the KP Tissue stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the KP Tissue stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze KP Tissue's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

KP Tissue Stock Price History

DateKP Tissue Price
11/29/20248.35 undefined
11/28/20248.32 undefined
11/27/20248.27 undefined
11/26/20248.27 undefined
11/25/20248.26 undefined
11/22/20248.27 undefined
11/21/20248.25 undefined
11/20/20248.19 undefined
11/19/20248.18 undefined
11/18/20248.27 undefined
11/15/20248.30 undefined
11/14/20248.30 undefined
11/13/20248.38 undefined
11/12/20248.17 undefined
11/11/20248.20 undefined
11/8/20248.29 undefined
11/7/20248.25 undefined
11/6/20248.20 undefined
11/5/20248.18 undefined
11/4/20248.25 undefined
11/1/20248.20 undefined

KP Tissue Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into KP Tissue, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by KP Tissue from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects KP Tissue’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of KP Tissue. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into KP Tissue’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing KP Tissue’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on KP Tissue’s growth potential.

KP Tissue Revenue, EBIT and net profit per share

DateKP Tissue RevenueKP Tissue EBITKP Tissue Net Income
2026e2.23 B undefined156.4 M undefined5.14 M undefined
2025e2.14 B undefined147.21 M undefined5.9 M undefined
2024e2.05 B undefined153.07 M undefined6.15 M undefined
20230 undefined0 undefined-4.94 M undefined
20220 undefined0 undefined-10.25 M undefined
20210 undefined0 undefined1.24 M undefined
20200 undefined0 undefined-1.95 M undefined
20190 undefined0 undefined-6.53 M undefined
20180 undefined0 undefined-170,000 undefined
20170 undefined0 undefined-5.44 M undefined
20160 undefined0 undefined-1.72 M undefined
20150 undefined0 undefined-31.34 M undefined
20140 undefined0 undefined-2.52 M undefined
20130 undefined0 undefined-290,000 undefined
20120 undefined0 undefined-840,000 undefined

KP Tissue Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (B)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (M)NET INCOME (M)NET INCOME GROWTH (%)DIV. ()DIV. GROWTH (%)SHARES (M)DOCUMENTS
2012201320142015201620172018201920202021202220232024e2025e2026e
0000000000002.052.142.23
-------------4.044.12
---------------
000000000000000
00-2-31-1-50-6-11-10-4655
---1,450.00-96.77400.00---83.33-200.00-1,100.00-60.00-250.00-16.67-
---------------
---------------
88.758.838.919.049.169.329.549.79.849.949.96000
---------------
Details

Keystats

ⓘ

Revenue and Growth

The KP Tissue Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the KP Tissue is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (M)RECEIVABLES (M)OTHER REC. (k)INVENTORIES (M)OTHER CURRENT LIAB. (M)CURRENT ASSETS (M)TANGIBLE ASSETS (M)LONG-T. INVEST. (M)LONG-T. REC. (M)INTANGIBLE ASSETS (M)GOODWILL (M)OTHER NON-CURRENT ASSETS (k)NON-CURRENT ASSETS (M)TOTAL ASSETS (M)LIABILITIESCOMMON STOCK (M)ADDITIONAL PAID-IN CAPITAL (M)RETAINED EARNINGS (k)OTHER EQUITY (M)UNREAL. GAINS/LOSSES (M)EQUITY (M)LIABILITIES (M)PROVISIONS (M)OTHER SHORT-TERM LIAB. (M)SHORT-TERM DEBTS (M)LONG-TERM DEBT PORTION (M)SHORT-TERM REC. (M)LONG-T. LIAB. (M)DEFERRED TAXES (M)OTHER LIAB. (k)LONG-T. LIABILITIES (M)DEBT (M)TOTAL CAPITAL (M)
201220132014201520162017201820192020202120222023
                       
000000000000
01.61.61.61.61.71.71.71.81.781.790
00080050080050030002085800
000000000000
000000000000
01.61.62.42.12.52.221.81.992.370
000000000000
139.5161.6153.7126.6117.398.799.481.169.578.7379.3468.16
0000000001.992.370
000000000000
000000000000
10000000000000
139.6161.6153.7126.6117.398.799.481.169.580.7281.7168.16
139.6163.2155.3129119.4101.2101.683.171.382.7184.0868.16
                       
1409.110.111.613.21517.11920.421.8422.3822.56
0144.8144.8144.8144.8144.8144.8144.8144.8144.82144.82144.82
-600700-12,200-49,300-58,700-75,000-82,300-100,700-111,900-103,561-108,008-115,027
0.23.47.918.115.81216.41413.112.7714.8416.01
000000000000
139.6158150.6125.2115.196.89677.166.475.8774.0368.36
000000000000
000000000000
02.22.72.23.421.72.84.44.041.962.25
000000000000
000000000000
02.22.72.23.421.72.84.44.041.962.25
000000000000
03210.91.53.63.20.60.815.720
000700070030000000
0321.70.92.23.93.20.60.815.720
05.24.73.94.34.25.6654.857.682.25
139.6163.2155.3129.1119.4101101.683.171.480.7281.7170.61
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of KP Tissue provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand KP Tissue's financial health and stability.

Assets

KP Tissue's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that KP Tissue must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of KP Tissue after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into KP Tissue's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (k)DEPRECIATION (M)DEFERRED TAXES (k)CHANGES IN WORKING CAPITAL (M)NON-CASH ITEM (M)PAID INTEREST (M)PAID TAXES (M)NET CASH FLOW FROM OPERATING ACTIVITIES (M)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (M)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (M)NET CHANGE IN EQUITY (M)CASH FLOW FROM FINANCING ACTIVITIES (M)CASH FLOW FROM OTHER FINANCING ACTIVITIES ()TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (M)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
201220132014201520162017201820192020202120222023
00-2,000-31,000-1,000-5,0000-6,000-1,0001,000-10,000-4,000
000000000000
01,0000000000-2,000-1,0000
000000000000
0-123115061-1104
000000000000
000101001200
000000000000
000000000000
-140-85544445566
-140-85544445566
000000000000
000000000000
140131000000000
1408-5-5-4-4-4-4-5-5-6-6
------------
0-5-6-5-4-4-4-4-5-5-6-6
000000000000
000000000000
000000000000

KP Tissue stock margins

The KP Tissue margin analysis displays the gross margin, EBIT margin, as well as the profit margin of KP Tissue. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for KP Tissue.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the KP Tissue's sales revenue. A higher gross margin percentage indicates that the KP Tissue retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the KP Tissue's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the KP Tissue's total revenue generated. When comparing the revenue margin year over year, investors can gauge the KP Tissue's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the KP Tissue. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the KP Tissue's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

KP Tissue Margin History

KP Tissue Gross marginKP Tissue Profit marginKP Tissue EBIT marginKP Tissue Profit margin
2026e0 %7.03 %0.23 %
2025e0 %6.89 %0.28 %
2024e0 %7.45 %0.3 %
20230 %0 %0 %
20220 %0 %0 %
20210 %0 %0 %
20200 %0 %0 %
20190 %0 %0 %
20180 %0 %0 %
20170 %0 %0 %
20160 %0 %0 %
20150 %0 %0 %
20140 %0 %0 %
20130 %0 %0 %
20120 %0 %0 %

KP Tissue Stock Sales Revenue, EBIT, Earnings per Share

The KP Tissue earnings per share therefore indicates how much revenue KP Tissue has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue KP Tissue earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates KP Tissue's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of KP Tissue’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating KP Tissue's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

KP Tissue Revenue, EBIT and net profit per share

DateKP Tissue Sales per ShareKP Tissue EBIT per shareKP Tissue Earnings per Share
2026e222.78 undefined0 undefined0.52 undefined
2025e213.97 undefined0 undefined0.59 undefined
2024e205.66 undefined0 undefined0.62 undefined
20230 undefined0 undefined-0.5 undefined
20220 undefined0 undefined-1.03 undefined
20210 undefined0 undefined0.13 undefined
20200 undefined0 undefined-0.2 undefined
20190 undefined0 undefined-0.68 undefined
20180 undefined0 undefined-0.02 undefined
20170 undefined0 undefined-0.59 undefined
20160 undefined0 undefined-0.19 undefined
20150 undefined0 undefined-3.52 undefined
20140 undefined0 undefined-0.29 undefined
20130 undefined0 undefined-0.03 undefined
20120 undefined0 undefined-0.11 undefined

KP Tissue business model

KP Tissue Inc is a Canadian company that was founded in 2012 and is based in Toronto. The company is involved in the manufacturing and distribution of personal and household paper products. KP Tissue Inc is a joint venture between Kruger Products L.P. and private equity firm BMO Capital Partners. Kruger Products L.P. is a well-known Canadian paper products manufacturer. KP Tissue is one of the most popular companies on Eulerpool.com.

KP Tissue SWOT Analysis

Strengths

KP Tissue Inc is a leading company in the tissue industry, with a strong market presence and customer base.

The company operates efficient manufacturing facilities, allowing for cost-effective production and competitive pricing.

KP Tissue has established strong relationships with key suppliers, ensuring a reliable supply chain for its raw materials.

The company's strong financial position allows for investments in research and development, innovation, and future growth opportunities.

Weaknesses

KP Tissue faces intense competition from other established players in the tissue industry, making it challenging to maintain market share.

The company's heavy reliance on pulp and paper as raw materials exposes it to fluctuations in prices and availability.

KP Tissue may lack diversification in its product portfolio, potentially limiting growth opportunities in other sectors.

Opportunities

The increasing global demand for tissue products presents a significant growth opportunity for KP Tissue to expand its market reach.

Emerging markets, such as Asia and Latin America, offer untapped potential for the company to enter and capture market share.

Growing consumer awareness of sustainable and eco-friendly products creates an opportunity for KP Tissue to position itself as a leader in environmentally friendly tissue products.

Threats

Changes in government regulations and environmental policies can impact KP Tissue's operations and increase compliance costs.

Economic downturns and fluctuations in consumer spending can affect the demand for tissue products and, consequently, KP Tissue's sales.

The tissue industry's reliance on single-use disposable products may face challenges from societal shifts towards more sustainable and reusable alternatives.

LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2

KP Tissue Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

KP Tissue historical P/E ratio, EBIT multiple, and P/S ratio

LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2

KP Tissue shares outstanding

The number of shares was KP Tissue in 2023 — This indicates how many shares 9.956 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue KP Tissue earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates KP Tissue's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of KP Tissue’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating KP Tissue's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

KP Tissue dividend history and estimates

In 2023, KP Tissue paid a dividend amounting to 0.72 CAD. Dividend means that KP Tissue distributes a portion of its profits to its owners.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Dividend
Dividend (Estimate)
Details

Dividend

ⓘ

Dividend Overview

The dividend per year chart for KP Tissue provides a comprehensive view of the annual dividends distributed to shareholders. Analyze the trend to understand the consistency and growth in dividend payouts over the years.

Interpretation and Use

A consistent or increasing trend in dividends can indicate the company's profitability and financial health. Investors can use this data to identify KP Tissue’s potential for long-term investment and income generation through dividends.

Investment Strategy

Incorporate the dividend data in evaluating KP Tissue's overall performance. A thorough analysis, considering other financial aspects, will help in making informed investment decisions for optimal capital growth and income generation.

KP Tissue Dividend History

DateKP Tissue Dividend
2026e1.19 undefined
2025e1.19 undefined
2024e1.19 undefined
20230.72 undefined
20220.72 undefined
20210.72 undefined
20200.72 undefined
20190.72 undefined
20180.72 undefined
20170.72 undefined
20160.72 undefined
20150.72 undefined
20140.72 undefined
20130.76 undefined

KP Tissue dividend payout ratio

In 2023, KP Tissue had a payout ratio of 571.56%. The payout ratio indicates the percentage of the company's profits that KP Tissue distributes as dividends.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Payout ratio
Details

Payout ratio

ⓘ

What is Yearly Payout Ratio?

The yearly payout ratio for KP Tissue represents the proportion of earnings paid out as dividends to shareholders. It is an indicator of the company's financial health and stability, illustrating how much profit is being returned to investors versus being reinvested back into the company.

How to Interpret the Data

A lower payout ratio for KP Tissue could mean that the company is reinvesting more into its growth, whereas a higher ratio indicates more earnings are being distributed as dividends. Investors seeking regular income might prefer companies with a higher payout ratio, while those looking for growth may opt for companies with a lower ratio.

Using the Data for Investments

Evaluate KP Tissue's payout ratio in conjunction with other financial metrics and performance indicators. A sustainable payout ratio, coupled with strong financial health, can indicate a reliable dividend payout. However, a very high ratio might suggest the company is not sufficiently reinvesting in its future growth.

KP Tissue Payout Ratio History

DateKP Tissue Payout ratio
2026e571.56 %
2025e571.56 %
2024e571.56 %
2023571.56 %
2022-69.8 %
2021571.56 %
2020-360 %
2019-105.88 %
2018-3,600 %
2017-122.03 %
2016-378.95 %
2015-20.45 %
2014-248.28 %
2013-2,523.33 %
2012571.56 %
LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2
Unfortunately, there are currently no price targets and forecasts available for KP Tissue.

KP Tissue latest earnings and earnings surprises

DateEPS EstimateEPS ActualQuarterly report
9/30/20240.16 0.21  (34.1 %)2024 Q3
6/30/20240.2 0.12  (-40.59 %)2024 Q2
3/31/20240.16 0.11  (-31.93 %)2024 Q1
12/31/20230.21 0.2  (-5.7 %)2023 Q4
9/30/20230.15 0.18  (18.81 %)2023 Q3
6/30/20230.05 0.2  (296.04 %)2023 Q2
3/31/2023-0.09 -1.07  (-1,145.63 %)2023 Q1
12/31/2022-0.03 -0.1  (-196.74 %)2022 Q4
9/30/2022-0.14 -0.63  (-365.63 %)2022 Q3
6/30/2022-0.21 -0.4  (-88.59 %)2022 Q2
1
2
3
4
...
5

Eulerpool ESG Scorecard© for the KP Tissue stock

Eulerpool World ESG Rating (EESG©)

21/ 100

🌱 Environment

30

👫 Social

11

🏛️ Governance

24

Environment

Scope 1 - Direct Emissions
Scope 2 - Indirect emissions from purchased energy
Scope 3 - Indirect emissions within the value chain
Total CO₂ emissions
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather
Pesticides
Palm Oil
Tobacco
Genetically modified organisms
Climate concept
Sustainable forestry
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency

Social

Percentage of female employees
Percentage of women in management
Percentage of Asian employees
Share of Asian management
Percentage of Hispanic/Latino employees
Hispano/Latino Management share
Percentage of Black employees
Black Management Share
Percentage of white employees
White Management Share
Adult content
Alcohol
Weapons
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept
Occupational health and safety
Catholic

Governance (Corporate Governance)

Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

KP Tissue shareholders

%
Name
Stocks
Change
Date
7.51090 % Caisse de Depot et Placement du Quebec750,155-452,0453/31/2024
0.80537 % Dimensional Fund Advisors, L.P.80,43708/31/2024
0.22408 % Spraley (David)22,38022,3809/9/2024
0.21906 % Bianco (Dino Joe)21,87945710/15/2024
0.20626 % Dimensional Fund Advisors, Ltd.20,60009/30/2024
0.10513 % Kruger Ii, Joseph10,50010,5004/17/2023
0.08531 % DFA Australia Ltd.8,5208,5204/30/2024
0.02503 % Kruger (Sarah Astrea)2,5002,5008/27/2024
0.02004 % Stewart (Charles William Alexander)2,002417/15/2024
0.00901 % Keays (Michael)9007508/16/2024
1
2

KP Tissue Executives and Management Board

Mr. Dino Bianco

(61)
KP Tissue Chief Executive Officer
Compensation 867,986

Mr. Gordon Goss

KP Tissue Senior Vice President, General Manager - Consumer Business, USA and Mexico
Compensation 675,884

Mr. Michel Manseau

KP Tissue Senior Vice President, General Manager - Consumer Business, Canada
Compensation 551,684

Mr. Mark Holbrook

KP Tissue Chief Financial Officer
Compensation 508,082

Mr. John O Hara

KP Tissue Senior Vice President, General Counsel - Away from Home
Compensation 478,234
1
2
3

KP Tissue Supply Chain

NameRelationshipTwo-week correlationOne-month correlationThree-Month CorrelationSix-Month CorrelationOne Year CorrelationTwo-Year Correlation
Kimberly-Clark Stock
Kimberly-Clark
SupplierCustomer-0,070,720,40-0,23-0,260,59
1

Most common questions regarding KP Tissue

What values and corporate philosophy does KP Tissue represent?

KP Tissue Inc represents values of excellence, innovation, and sustainability. The company's corporate philosophy is centered around providing quality products and services to its customers while maintaining a focus on environmental responsibility. KP Tissue Inc strives to be a leader in the tissue industry by continuously improving its processes and leveraging cutting-edge technologies. With a commitment to social and environmental stewardship, the company aims to create long-term value for its stakeholders. KP Tissue Inc's dedication to these values and corporate philosophy sets it apart in the market, making it a trusted and sustainable choice for investors.

In which countries and regions is KP Tissue primarily present?

KP Tissue Inc is primarily present in Canada and the United States.

What significant milestones has the company KP Tissue achieved?

KP Tissue Inc has achieved several significant milestones throughout its history. One notable accomplishment is its acquisition of Orchids Paper Products, a leading manufacturer of tissue products, which has expanded the company's market reach and product offerings. Additionally, KP Tissue Inc has successfully established strategic partnerships with key retailers, further enhancing its distribution network and brand visibility. The company has also focused on investing in advanced manufacturing technologies to improve efficiency and product quality. With a strong commitment to innovation and customer satisfaction, KP Tissue Inc continues to make strides in the tissue industry, ensuring its position as a trusted and reliable provider of high-quality tissue products.

What is the history and background of the company KP Tissue?

KP Tissue Inc is a Canadian company that specializes in the manufacturing and distribution of tissue products. Founded in 2012, KP Tissue Inc has quickly become a prominent player in the industry. The company operates through its subsidiary, Kruger Products L.P., which is a leading manufacturer of tissue and paper products in North America. With a rich history spanning several decades, KP Tissue Inc has built a strong reputation for delivering high-quality and innovative tissue solutions to consumers and businesses. The company's commitment to sustainability and customer satisfaction has contributed to its continued growth and success in the market. KP Tissue Inc continues to be a trusted name in the tissue industry, offering products that meet the needs of a diverse customer base.

Who are the main competitors of KP Tissue in the market?

The main competitors of KP Tissue Inc in the market are Cascades Inc and Clearwater Paper Corporation.

In which industries is KP Tissue primarily active?

KP Tissue Inc is primarily active in the tissue industry.

What is the business model of KP Tissue?

The business model of KP Tissue Inc is focused on manufacturing and distributing a wide range of tissue products. As a leading Canadian consumer product company, KP Tissue Inc specializes in producing and distributing bathroom tissues, paper towels, and facial tissues primarily under the brand name "Cashmere." The company's business model includes a vertically integrated approach, with operations involving the production of finished products, sourcing raw materials, and managing distribution channels. Through strategic partnerships and a commitment to quality, KP Tissue Inc aims to meet the growing demand for tissue products while delivering value to its customers and shareholders.

What is the P/E ratio of KP Tissue 2024?

The KP Tissue P/E ratio is 13.51.

What is the P/S ratio of KP Tissue 2024?

The KP Tissue P/S ratio is 0.04.

What is the Quality Investing of KP Tissue?

The Quality Investing for KP Tissue is 2/10.

What is the revenue of KP Tissue 2024?

The expected KP Tissue revenue is 2.05 B CAD.

How high is the profit of KP Tissue 2024?

The expected KP Tissue profit is 6.15 M CAD.

What is the business model of KP Tissue

KP Tissue Inc. is a leading manufacturer of paper products, specializing in the production of toilet paper, paper towels, and tissues. The company operates three different business segments: Kruger Products L.P., Kruger Products (USA) Inc., and KPLP Finance Co. KP Tissue Inc. is a Canadian company listed on the Toronto Stock Exchange under the symbol KPT. Kruger Products L.P. is one of the largest toilet paper, paper towel, and tissue manufacturers in Canada. The company has been continuously growing since its establishment in 1904 and has a wide range of products sold under various brands, including Cashmere, Purex, SpongeTowels, Scotties, and White Swan. Kruger Products L.P. takes pride in manufacturing all its products from 100% recycled paper, making it one of the most environmentally friendly toilet paper, paper towel, and tissue manufacturers. Kruger Products (USA) Inc. is the American counterpart to Kruger Products L.P. The company is based in Memphis, Tennessee, and specializes in the production of paper products. Kruger Products (USA) Inc. sells its products under various brands, such as White Cloud, Preference, and Jumbo. KPLP Finance Co. is a subsidiary of KP Tissue Inc. and is a pure financial service provider. The company ensures that its subsidiaries have sufficient capital and resources to continue their businesses successfully. The toilet paper, paper towel, and tissue brands of KP Tissue Inc. have an excellent reputation and are highly popular among consumers in Canada and the USA. The company places special emphasis on the quality of its products and has even developed the "Ultimate Use Experience" to allow customers to experience a product in action. The goal is to develop a great product that meets the needs of consumers. All products from KP Tissue Inc. are made from 100% recycled paper, making them environmentally friendly. Overall, the business model of KP Tissue Inc. is very successful, and there is great potential for growth and expansion. The company has earned an excellent reputation in the industry and is on track to solidify its position as a leading manufacturer of paper products in North America.

What is the KP Tissue dividend?

KP Tissue pays a dividend of 0.72 CAD distributed over payouts per year.

How often does KP Tissue pay dividends?

The dividend cannot currently be calculated for KP Tissue or the company does not pay out a dividend.

What is the KP Tissue ISIN?

The ISIN of KP Tissue is CA48265Y1043.

What is the KP Tissue WKN?

The WKN of KP Tissue is A1KAN1.

What is the KP Tissue ticker?

The ticker of KP Tissue is KPT.TO.

How much dividend does KP Tissue pay?

Over the past 12 months, KP Tissue paid a dividend of 0.72 CAD . This corresponds to a dividend yield of about 8.62 %. For the coming 12 months, KP Tissue is expected to pay a dividend of 1.19 CAD.

What is the dividend yield of KP Tissue?

The current dividend yield of KP Tissue is 8.62 %.

When does KP Tissue pay dividends?

KP Tissue pays a quarterly dividend. This is distributed in the months of July, October, October, January.

How secure is the dividend of KP Tissue?

KP Tissue paid dividends every year for the past 14 years.

What is the dividend of KP Tissue?

For the upcoming 12 months, dividends amounting to 1.19 CAD are expected. This corresponds to a dividend yield of 14.25 %.

In which sector is KP Tissue located?

KP Tissue is assigned to the 'Non-cyclical consumption' sector.

Wann musste ich die Aktien von KP Tissue kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of KP Tissue from 1/15/2025 amounting to 0.18 CAD, you needed to have the stock in your portfolio before the ex-date on 12/31/2024.

When did KP Tissue pay the last dividend?

The last dividend was paid out on 1/15/2025.

What was the dividend of KP Tissue in the year 2023?

In the year 2023, KP Tissue distributed 0.72 CAD as dividends.

In which currency does KP Tissue pay out the dividend?

The dividends of KP Tissue are distributed in CAD.

All fundamentals about KP Tissue

Our stock analysis for KP Tissue Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of KP Tissue Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.